Heart Failure Trials in heerlen, netherlands
Conditions / Heart Failure / heerlen, netherlands
Clinical trials for Heart Failure investigate a range of treatment strategies and patient populations.
13 total trials for this combination
Showing top 10 of 13 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00206310 | Crestor Versus Placebo in Subjects With Heart Failure | COMPLETED | PHASE3 |
| NCT03057977 | EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced) | COMPLETED | PHASE3 |
| NCT00358215 | RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial | COMPLETED | PHASE3 |
| NCT02111564 | A Study of Rivaroxaban (JNJ-39039039) on the Venous Thromboembolic Risk in Post-Hospital Discharge Patients | COMPLETED | PHASE3 |
| NCT01877915 | A Study to Assess the Effectiveness and Safety of Rivaroxaban in Reducing the Risk of Death, Myocardial Infarction or Stroke in Participants With Heart Failure and Coronary Artery Disease Following an Episode of Decompensated Heart Failure | COMPLETED | PHASE3 |
| NCT05737940 | A Study of AZD3427 in Participants With Heart Failure and Pulmonary Hypertension Group 2 | COMPLETED | PHASE2 |
| NCT03057951 | EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved) | COMPLETED | PHASE3 |
| NCT05636176 | A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation | RECRUITING | PHASE3 |
| NCT00232180 | A Comparison Of Outcomes In Patients In New York Heart Association (NYHA) Class II Heart Failure When Treated With Eplerenone Or Placebo In Addition To Standard Heart Failure Medicines | COMPLETED | PHASE3 |
| NCT06979375 | A Research Study Comparing CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Reduced/Mildly Reduced Ejection Fraction and Left Ventricular Hypertrophy | RECRUITING | PHASE2 |